- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 175 results
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
October 25, 2022
The Updated OIG Model CIAs – What All Healthcare Organizations Need to Know
Speaking Engagement
September 20, 2022
Eva Temkin to Speak at DIA’s Biosimilars Conference
Speaking Engagement
September 15, 2022
Eva Temkin to Speak on FDANews Webinar
Conference
September 7, 2022
15th Annual King & Spalding Medical Device Summit
Webinar
August 18, 2022
An Analysis of the Prescription Drug Pricing Provisions of the Inflation Reduction Act of 2022
Speaking Engagement
August 11, 2022
Gary Messplay to Speak at Regulatory Affairs Professionals Society Conference
Webinar
July 28, 2022
The Drug Supply Chain Security Act – Are Your Operations Ready for Final Implementation?
Speaking Engagement
June 29, 2022
Heather Banuelos, Gillian Russell to Speak at Food and Drug Law Institute’s Introduction to Drug Law and Regulation Course
Speaking Engagement
June 28, 2022
Eva Temkin to Interview M. Stacey Ricci About Biosimilars and Interchangeable Products